-
1
-
-
22044447915
-
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: Results in 8000 patients
-
Koo JY, Fleischer AB Jr, Abramovits W, Pariser DM, McCall CO, Horn TD, et al. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: Results in 8000 patients. J Am Acad Dermatol. 2005;53:S195-205.
-
(2005)
J Am Acad Dermatol
, vol.53
-
-
Koo, J.Y.1
Fleischer Jr, A.B.2
Abramovits, W.3
Pariser, D.M.4
McCall, C.O.5
Horn, T.D.6
-
2
-
-
0242322394
-
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group
-
Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med. 1997;337:816-821.
-
(1997)
N Engl J Med
, vol.337
, pp. 816-821
-
-
Ruzicka, T.1
Bieber, T.2
Schopf, E.3
Rubins, A.4
Dobozy, A.5
Bos, J.D.6
-
3
-
-
21644486852
-
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis
-
Reitamo S, Ortonne JP, Sand C, Cambazard F, Bieber T, Folster-Holst R, et al. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol. 2005;152:1282-1289.
-
(2005)
Br J Dermatol
, vol.152
, pp. 1282-1289
-
-
Reitamo, S.1
Ortonne, J.P.2
Sand, C.3
Cambazard, F.4
Bieber, T.5
Folster-Holst, R.6
-
4
-
-
22044449340
-
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis
-
Hanifin JM, Paller AS, Eichenfield L, Clark RA, Korman N, Weinstein G, et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol. 2005;53(suppl 2):S186-194.
-
(2005)
J Am Acad Dermatol
, vol.53
, Issue.SUPPL. 2
-
-
Hanifin, J.M.1
Paller, A.S.2
Eichenfield, L.3
Clark, R.A.4
Korman, N.5
Weinstein, G.6
-
5
-
-
51849154755
-
A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients
-
Reitamo S, Rustin M, Harper J, Kalimo K, Rubins A, Cambazard F, et al. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. Br J Dermatol. 2008;159:942-951.
-
(2008)
Br J Dermatol
, vol.159
, pp. 942-951
-
-
Reitamo, S.1
Rustin, M.2
Harper, J.3
Kalimo, K.4
Rubins, A.5
Cambazard, F.6
-
6
-
-
76749126330
-
-
Astellas Pharma Data on file (MS MIDAS - MAT Sept 2008). 2008; reference #5249.
-
Astellas Pharma Data on file (MS MIDAS - MAT Sept 2008). 2008; reference #5249.
-
-
-
-
9
-
-
33745427100
-
New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene- environment interactions
-
Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene- environment interactions. J Allergy Clin Immunol. 2006;118:3-21.
-
(2006)
J Allergy Clin Immunol
, vol.118
, pp. 3-21
-
-
Cork, M.J.1
Robinson, D.A.2
Vasilopoulos, Y.3
Ferguson, A.4
Moustafa, M.5
MacGowan, A.6
-
10
-
-
76749127061
-
-
Astellas Pharma GmbH Summaries of product characteristics. Protopic 0.03% ointment and Protopic 0.1% ointment. Munich: Astellas Pharma GmbH; 2009.
-
Astellas Pharma GmbH Summaries of product characteristics. Protopic 0.03% ointment and Protopic 0.1% ointment. Munich: Astellas Pharma GmbH; 2009.
-
-
-
-
11
-
-
42549123345
-
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment
-
Wollenberg A, Reitamo S, Girolomoni G, Lahfa M, Ruzicka T, Healy E, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 2008;63:742-750.
-
(2008)
Allergy
, vol.63
, pp. 742-750
-
-
Wollenberg, A.1
Reitamo, S.2
Girolomoni, G.3
Lahfa, M.4
Ruzicka, T.5
Healy, E.6
-
12
-
-
56549121036
-
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: Results of a randomized, multicentre, comparative study
-
Thaçi D, Reitamo S, Gonzalez Ensenat MA, Moss C, Boccaletti V, Cainelli T, et al. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: Results of a randomized, multicentre, comparative study. Br J Dermatol. 2008;159:1348-1356.
-
(2008)
Br J Dermatol
, vol.159
, pp. 1348-1356
-
-
Thaçi, D.1
Reitamo, S.2
Gonzalez Ensenat, M.A.3
Moss, C.4
Boccaletti, V.5
Cainelli, T.6
-
13
-
-
0001779228
-
Diagnostic features of atopic dermatitis
-
Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;suppl 92:44-47.
-
(1980)
Acta Derm Venereol (Stockh)
, Issue.SUPPL. 92
, pp. 44-47
-
-
Hanifin, J.M.1
Rajka, G.2
-
14
-
-
0024352509
-
Grading the severity of atopic dermatitis
-
Rajka G, Langeland T. Grading the severity of atopic dermatitis. Acta Derm Venereol (Stockh). 1989;suppl 144:13-14.
-
(1989)
Acta Derm Venereol (Stockh)
, Issue.SUPPL. 144
, pp. 13-14
-
-
Rajka, G.1
Langeland, T.2
-
15
-
-
0036553479
-
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
-
Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K, et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol. 2002;46:495-504.
-
(2002)
J Am Acad Dermatol
, vol.46
, pp. 495-504
-
-
Eichenfield, L.F.1
Lucky, A.W.2
Boguniewicz, M.3
Langley, R.G.4
Cherill, R.5
Marshall, K.6
-
16
-
-
0028332995
-
Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use
-
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.
-
(1994)
Clin Exp Dermatol
, vol.19
, pp. 210-216
-
-
Finlay, A.Y.1
Khan, G.K.2
-
17
-
-
0029019718
-
The Children's Dermatology Life Quality Index (CDLQI): Initial validation and practical use
-
Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): Initial validation and practical use. Br J Dermatol. 1995;132:942-949.
-
(1995)
Br J Dermatol
, vol.132
, pp. 942-949
-
-
Lewis-Jones, M.S.1
Finlay, A.Y.2
-
18
-
-
33746110622
-
An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: Further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score
-
Beattie PE, Lewis-Jones MS. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: Further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score. Br J Dermatol. 2006;155: 1249-1255.
-
(2006)
Br J Dermatol
, vol.155
, pp. 1249-1255
-
-
Beattie, P.E.1
Lewis-Jones, M.S.2
-
19
-
-
33750001127
-
Pruritus as a leading symptom: Clinical characteristics and quality of life in German and Ugandan patients
-
Weisshaar E, Apfelbacher C, Jager G, Zimmermann E, Bruckner T, Diepgen TL, et al. Pruritus as a leading symptom: Clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol. 2006;155:957-964.
-
(2006)
Br J Dermatol
, vol.155
, pp. 957-964
-
-
Weisshaar, E.1
Apfelbacher, C.2
Jager, G.3
Zimmermann, E.4
Bruckner, T.5
Diepgen, T.L.6
-
20
-
-
1842619231
-
The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization
-
Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm. 2002;8: 333-342.
-
(2002)
J Manag Care Pharm
, vol.8
, pp. 333-342
-
-
Fivenson, D.1
Arnold, R.J.2
Kaniecki, D.J.3
Cohen, J.L.4
Frech, F.5
Finlay, A.Y.6
-
21
-
-
3042555249
-
The itch
-
Launer J. The itch. QJM. 2004;97:383-384.
-
(2004)
QJM
, vol.97
, pp. 383-384
-
-
Launer, J.1
-
22
-
-
58249087940
-
Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: A new paradigm for use
-
Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: A new paradigm for use. Pediatrics. 2008;122:e1210-1218.
-
(2008)
Pediatrics
, vol.122
-
-
Paller, A.S.1
Eichenfield, L.F.2
Kirsner, R.S.3
Shull, T.4
Jaracz, E.5
Simpson, E.L.6
-
23
-
-
0035157535
-
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy
-
Hanifin JM, Ling MR, Langley R, Breneman D, Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy. J Am Acad Dermatol. 2001;44: S28-38.
-
(2001)
J Am Acad Dermatol
, vol.44
-
-
Hanifin, J.M.1
Ling, M.R.2
Langley, R.3
Breneman, D.4
Rafal, E.5
-
24
-
-
0035157895
-
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety
-
Soter NA, Fleischer AB Jr, Webster GF, Monroe E, Lawrence I. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety. J Am Acad Dermatol. 2001;44:S39-46.
-
(2001)
J Am Acad Dermatol
, vol.44
-
-
Soter, N.A.1
Fleischer Jr, A.B.2
Webster, G.F.3
Monroe, E.4
Lawrence, I.5
-
25
-
-
0035164433
-
A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients
-
Paller A, Eichenfield LF, Leung DY, Stewart D, Appell M. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 2001;44:S47-57.
-
(2001)
J Am Acad Dermatol
, vol.44
-
-
Paller, A.1
Eichenfield, L.F.2
Leung, D.Y.3
Stewart, D.4
Appell, M.5
-
26
-
-
0036130451
-
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis
-
Reitamo S, Rustin M, Ruzicka T, Cambazard F, Kalimo K, Friedmann PS, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol. 2002;109:547-555.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 547-555
-
-
Reitamo, S.1
Rustin, M.2
Ruzicka, T.3
Cambazard, F.4
Kalimo, K.5
Friedmann, P.S.6
-
27
-
-
0036128526
-
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis
-
Reitamo S, Van Leent EJ, Ho V, Harper J, Ruzicka T, Kalimo K, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol. 2002;109:539-546.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 539-546
-
-
Reitamo, S.1
Van Leent, E.J.2
Ho, V.3
Harper, J.4
Ruzicka, T.5
Kalimo, K.6
-
28
-
-
0037560964
-
Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: Randomised, double blind, parallel group study
-
Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van HO, Allegra F, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: Randomised, double blind, parallel group study. BMJ. 2003;326:1367.
-
(2003)
BMJ
, vol.326
, pp. 1367
-
-
Berth-Jones, J.1
Damstra, R.J.2
Golsch, S.3
Livden, J.K.4
Van, H.O.5
Allegra, F.6
-
29
-
-
40949107967
-
Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: A multicentre, randomized, double-blind, controlled study
-
Peserico A, Stadtler G, Sebastian M, Fernandez RS, Vick K, Bieber T. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: A multicentre, randomized, double-blind, controlled study. Br J Dermatol. 2008;158:801-807.
-
(2008)
Br J Dermatol
, vol.158
, pp. 801-807
-
-
Peserico, A.1
Stadtler, G.2
Sebastian, M.3
Fernandez, R.S.4
Vick, K.5
Bieber, T.6
-
30
-
-
20144388441
-
A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis
-
Harper J, Smith C, Rubins A, Green A, Jackson K, Zigure S, et al. A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis. J Invest Dermatol. 2005;124:695-699.
-
(2005)
J Invest Dermatol
, vol.124
, pp. 695-699
-
-
Harper, J.1
Smith, C.2
Rubins, A.3
Green, A.4
Jackson, K.5
Zigure, S.6
-
31
-
-
22044435818
-
Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis
-
Rubins A, Gutmane R, Valdmane N, Stevenson P, Foster C, Undre N. Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis. J Invest Dermatol. 2005;125:68-71.
-
(2005)
J Invest Dermatol
, vol.125
, pp. 68-71
-
-
Rubins, A.1
Gutmane, R.2
Valdmane, N.3
Stevenson, P.4
Foster, C.5
Undre, N.6
-
32
-
-
0141819272
-
The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis
-
Patel RR, Vander Straten MR, Korman NJ. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. Arch Dermatol. 2003;139:1184-1186.
-
(2003)
Arch Dermatol
, vol.139
, pp. 1184-1186
-
-
Patel, R.R.1
Vander Straten, M.R.2
Korman, N.J.3
|